is one of the major tools used in cellular and molecular biology, delivering excellent model systems for studying the normal physiology and biochemistry of cells the effects of drugs and toxic compounds on the cells, and mutagenesis and carcinogenesis. It is also used in drug screening and development, and large scale production of biological compounds. The major advantage of using cell culture for any of these applications is the consistency and reproducibility of results that can be obtained from using a batch of clonal cells. The global cell culture market
is mainly categorized into products, type, application, end user and by geography. The key products of cell culture consumables are media, sera and reagent.
The global cell culture market has grown significantly in the last ten years. The demand for artificial organs and biopharmaceuticals has boosted this market extensively in past and is likely to fuel its growth further in the coming years. Additionally, the rising usage of cell culture models in drug discoveries is expected to present an opportunity-rich market for major cell culture market players.
The global market for cell culture was assessed to be $xx bn in 2016. The cell culture market is projected to grow at a CAGR of xx% and is forecast to reach $xx bn by 2021. The 3D cell culture is forecast to have the maximum growth of xx% during the forecast period between 2016 and 2021. Cancer research laboratories and pharmaceutical companies are the major end-users for cell culture. North America and Europe alone are estimated to occupy a share of more than xx% during 2016-2021.
Europe is the leading market for cell culture with Germany being the frontrunner. Europe region is forecast to have highest growth in the next few years due to growing adoption of cell culture in industrial applications. Europe cell culture market accounts to xx% of the global market for cell culture and is the fastest growing market followed by Americas. In Americas, Biopharmaceuticals and University research institutes are the major end users of cell culture.
The key players profiled in this report:
- GE Healthcare
- Asahi Breweries, Ltd.
- Chugai Pharmaceutical Co.
- Kyowa Hakko Kirin Co., Ltd.
- Thermo Fisher Scientific
1. Market Overview
2. Executive Summary
3. Cell Culture Market- Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user Profiling
3.2.3. Top 5 Financials Analysis4. Cell Culture Market-Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.3. Attractiveness of the Cell Culture Industry
4.3.1. Power of Suppliers
4.3.2. Threats From New Entrants
4.3.3. Power of Buyer
4.3.4. Threat From Substitute Product
4.3.5. Degree of Competition5. Cell Culture Market-Strategic Analysis
5.1. Cell Culture Market - Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle
5.5. Suppliers and Distributors
5.6. Regulation Analysis6. Cell Culture Market By Type
6.2. Primary cell culture
6.3. Secondary cell culture
6.4. Monolayer culture
6.5. Others7. Cell Culture Market By Application
7.3. Cancer Research
7.4. Tissue culture and Engineering
7.5. Gene therapy
7.6. Drug Screening & Development
7.7. Others8. Cell Culture Market By Product
8.2. Basic Equipment
8.2.1. Cell culture hood
8.2.3. Water bath
8.2.6. Cell counter
8.2.7. Inverted microscope
8.3. Expanded Equipment
8.3.1. Aspiration pump
8.3.2. pH meter
8.3.3. Confocal microscope
8.3.4. Flow cytometer
8.4. Additional Supplies
8.4.2. Syringes and needles
8.4.3. Waste containers
8.4.4. Media, sera, and reagents
8.4.5. Cell culture vessels9. Cell Culture Market-By End User
9.2. Research Institutes
9.3. Bio technology Companies
9.4. Pharmaceutical Companies10. Cell Culture Market-By Geography
10.3.2. South Korea
10.4. Rest of The World (ROW)
10.4.2. Oceania11. Cell Culture Market-Entropy
11.1. New Product Developments
11.2. Mergers and Acquisitions12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.2. Sanofi Biologics.
12.3. LONZA Biologics
12.4. GSK Biologicals
12.5. GE Healthcare
12.6. ETH Zurich.
12.7. ProBioGen AG.
12.8. Ajinomoto Co., Inc
12.9. Asahi Breweries, Ltd.
12.10. Asahi Kasei Pharma
12.11. Astellas Pharma Inc
12.12. Chugai Pharmaceutical Co.
12.13. Cosmo Bio Co., Ltd.
12.14. Dainippon Sumitomo Pharma Co., Ltd.
12.15. Hitachi Plant Technologies, Ltd.
12.16. JCR Pharmaceuticals Co., Ltd.
12.17. Kyowa Hakko Kirin Co., Ltd.
12.18. NIHON PHARMACEUTICAL CO., LTD
12.19. Thermo Fisher Scientific *More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13.3. Research Methodology
13.5. Compilation of Expert Insights